Experience

Small molecule product development agreement for Roivant Sciences

Roivant Scientists

Drafted and negotiated a complex strategic development agreement for Roivant Sciences relating to a small molecule product with potential payments of up to $600 million.

Related Professionals

D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Lipid nanoparticle licensing and collaboration agreements for Genevant Sciences

Genevant Sciences

BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.

BioDelivery Sciences International, Inc. et al.

Chiron Corp. v. Eli Lilly and Vertex Pharmaceutical

Eli Lilly and Vertex Pharmaceuticals 

Multiple settlement and license agreements for AbbVie, Inc.

AbbVie, Inc.

BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd.

Fochon Pharmaceuticals, Ltd.

Patent strategy and portfolio development

Global prosecution and portfolio management for major pharmaceutical company

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

L'Oreal v. Revlon

L'Oreal

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.